As Sr. Clinical Development Director - Gastroenterology
, you will be the Clinical Development Lead (CDL) for a GI clinical program. You will lead the clinical team, with an opportunity to support multiple indications as part of this program's life cycle management plans. You will work as part of a cross-functional team to deliver on a high-priority program, while also contributing to a growing, dynamic, and collaborative Clinical Sciences community of physicians and scientists.Key responsibilities:
- Providing integrated and innovative clinical development strategy to support the creation and management of the Integrated Evidence Plan (IEP), including the Clinical Development Plan (CDP), for an asset in development
- Strategic Leadership: Integrating scientific rationale, regulatory requirements, product development plan and commercial goals to optimize clinical study designs aligned with the IEP and CDP
- Generating the data and evidence required to determine a medicine's potential efficacy, safety profile, key areas of product differentiation, and value to patients
- Establishing expeditious clinical development timelines and incorporating key decision points and Go/No-Go criteria for the CDP
- Developing and maintaining relationships with program counterparts, including Research, Regulatory, Clinical Operations, Statistics, and Commercial
- Contributing to and partnering on the development of strategic initiatives, specific Business Development activities, and various organizational initiatives in Clinical Development
- Playing an active role in the technical and leadership development of Clinical Sciences staff via coaching and mentoring.
Scientific Leadership, Direction and Strategy:
- Employing visionary and strategic thinking to provide expert leadership of disease/therapeutic area specific strategy for a drug(s) or program(s). Leading selected clinical development projects for products or a franchise of compounds
- Serving as a clinical point of contact for senior management and senior level matrix teams, both internally and externally for an asset(s) in development
- Leading, positively interfacing with, and influencing across a diverse range of scientific external experts (e.g. regulators, payors, CROs, consultants, investigators) in order to deliver an integrated clinical development strategy, which aligns to the business strategy and achieves mutual goals related to patient need
- Integrating inputs from across disciplines (e.g., scientific, clinical, commercial, regulatory) to contribute to the Medicine Profile. Accountable for the clinical components of the Medicine Profile.
- Accountable for risk/benefit of the asset. Actively leading and making decisions that balance risk/benefit at the project level with clear understanding of impact on study/project indication approvals; taking action to mitigate risk where appropriate
- Assessing and predicting when therapies designed for one patient population/indication can be used in alternative scenarios to broaden potential patient benefit
- Anticipating problems and proactively seeking input from other teams/functional lines within R&D. Using scientific/operational expertise to solve study and/or project related problems
- Accountable for the evaluation of clinical study/program probability of technical success (PTS)
Study & Program Design and Evidence Generation:
- Driving an end-to-end integrated clinical development strategy that is appropriately resourced to achieve regulatory approvals, reimbursable medicines, and successful lifecycle management
- Leading clinical development discussions at regulatory interactions; accountable for clinical components of regulatory submissions (i.e. IND, NDA, BLA, MAA), including briefing documents, presentations, addressing questions and responses
- Providing effective leadership support / oversight of evidence generation activities to ensure patient safety and study delivery
- Delivering value and access insights to inform medical strategy, expand market access, and address unmet patient need
Creating Innovative Scientific and Technical Solutions
Why you?Basic Qualifications:
- Overcoming obstacles by experimenting with and adopting new ways of working including digital tools and technology
- Championing implementation of innovative methods and processes within clinical development and gaining stakeholder support; encouraging others to think differently and come up with business solutions
- MD, PhD, and/or PharmD degree
- Extensive clinical training and/or applicable clinical research experience; understanding of clinical development planning and running clinical trials from concept study idea to publication
- An understanding of the gastroenterology disease space, the underlying biology, and potential therapeutic targets, as well as current and future potential treatment options
- Demonstrated experience managing complex projects and working collaboratively with multiple stakeholders regarding new strategies to ensure consistent communication
- Robust knowledge of ICH guidelines, FDA requirements, regulatory and reimbursement data requirements in responsible area
- Solid understanding of needs and priorities of regulators, payers, and prescribers in relevant market(s)
- Significant years of experience leading line and matrix teams with a strong reputation of inspiring and motivating high performance
- Thorough understanding of clinical research methodology and biostatistics principles, to facilitate innovative and efficient clinical trial design, and clinical development plans with clear data-driven decision rules
- Demonstrated experience using new learning and digital tools to create innovation in other areas
- Expertise in inductive and deductive reasoning, statistics, and in providing mechanisms to interpret and analyze highly complex information, including digital content
Why GSK?Uniting science, talent, and technology to get ahead of disease together
- Extensive experience in clinical drug development within the GI disease area
- Demonstrated experience integrating genetic data to inform and guide clinical protocols
At GSK, we have already delivered unprecedented change over the past four years, improving R&D, becoming a leader in Consumer Healthcare, strengthening our leadership, and transforming our commercial execution. Now, we're making the most significant changes we've made to our business in over 20 years. We're on track to separate and create two new companies in 2022:
New GSK with a leading portfolio of vaccines and specialty medicines as well as R&D based on immune system and genetics science; and a new world-leading consumer healthcare company of loved and trusted brands.
With new ambition comes new purpose. For New GSK, this is to unite science, talent, and technology to get ahead of disease together - all with the clear ambition of delivering human health impact; stronger and more sustainable shareholder returns; and as a new GSK where outstanding people thrive.
Getting ahead means preventing disease as well as treating it. How we do all this is through our people and our culture. A culture that isambitious for patients
- so we deliver what matters better and faster;accountable for impact
- with clear ownership of goals and support to succeed; and where we do the right thing
. So, if you're ready to improve the lives of billions, join us at this exciting moment in our journey. Join our challenge to get Ahead Together.
Closing date for applications: 30 June 2022
If you require an accommodation or other assistance to apply for a job at GSK, please contact the GSK Service Centre at 1-877-694-7547 (US Toll Free) or +1 801 567 5155 (outside US).
GSK is an Equal Opportunity Employer and, in the US, we adhere to Affirmative Action principles. This ensures that all qualified applicants will receive equal consideration for employment without regard to race, color, national origin, religion, sex, pregnancy, marital status, sexual orientation, gender identity/expression, age, disability, genetic information, military service, covered/protected veteran status or any other federal, state or local protected class.
At GSK, the health and safety of our employees are of paramount importance. As a science-led healthcare company on a mission to get ahead of disease together, we believe that supporting vaccination against COVID-19 is the single best thing we can do in the US to ensure the health and safety of our employees, complementary workers, workplaces, customers, consumers, communities, and the patients we serve.
GSK has made the decision to require all US employees to be fully vaccinated against COVID-19, where allowed by state or local law and where vaccine supply is readily available. The only exceptions to this requirement are employees who are approved for an accommodation for religious, medical or disability-related reasons.
Important notice to Employment businesses/ Agencies
GSK does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact GSK's commercial and general procurement/human resources department to obtain prior written authorization before referring any candidates to GSK. The obtaining of prior written authorization is a condition precedent to any agreement (verbal or written) between the employment business/ agency and GSK. In the absence of such written authorization being obtained any actions undertaken by the employment business/agency shall be deemed to have been performed without the consent or contractual agreement of GSK. GSK shall therefore not be liable for any fees arising from such actions or any fees arising from any referrals by employment businesses/agencies in respect of the vacancies posted on this site.
Please note that if you are a US Licensed Healthcare Professional or Healthcare Professional as defined by the laws of the state issuing your license, GSK may be required to capture and report expenses GSK incurs, on your behalf, in the event you are afforded an interview for employment. This capture of applicable transfers of value is necessary to ensure GSK's compliance to all federal and state US Transparency requirements. For more information, please visit GSK's Transparency Reporting For the Record